Forbes October 2, 2024
Tom Niehaus is Executive Vice President, North America, at CTG.
The artificial intelligence revolution has arrived in healthcare, with the technology transforming everything from diagnostics to drug discovery to personalized treatments—processes largely unseen by the patient but which improve their lives.
Despite this positive impact, research shows there are ongoing concerns about the use of AI in healthcare generally. According to a Pew Research survey, 57% of Americans say the use of AI for clinical interactions, such as disease diagnosis and treatment recommendations, would make the patient-provider relationship worse.
This perception gap between the very real positive impact of AI in healthcare and the concerns about its effect on patient-provider trust must be addressed by healthcare organizations as they adopt...